arrow
申

申楠 (Nan Shen)

Southern University of Science and Technology
H指数:21
被引数:1,588

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liposomal irinotecan (Lipo-IRI) alone or in combination with famitinib or platinum for patients with extensive-stage small cell lung cancer (ES-SCLC) after failure of first-line immunotherapy: A multicenter, randomized, open-label, multicohort phase II trial

脂质体伊立替康(Lipo-IRI)单药或联合法米替尼或铂类药物用于接受一线免疫治疗失败的广泛期小细胞肺癌(ES-SCLC)患者的治疗:一项多中心、随机、开放标签、多队列II期临床试验

2024-12-010
PRE